Loading
TGF Β Signaling in Diseases / Wnt/β Catenin Signaling in Development and Cancer · Journal article
International Journal of Biological Macromolecules · July 14, 2026
Encouraging direction, but not yet definitive.
This preclinical study demonstrates that Engrailed 1 is a critical positive regulator of osteoblastic differentiation and bone repair in a murine calvarial defect model using gain- and loss-of-function CRISPR approaches. While the molecular and functional consistency is encouraging, the work remains mechanistic and animal-based, with no human data or clinical translation reported.
Preclinical mechanistic study with CRISPR-based gain- and loss-of-function and murine in vivo bone defect model. Immortalized adipose-derived mesenchymal stromal cells; mice with calvarial bone defects (species and strain not specified). Intervention: CRISPR-Cas9-based En1 overexpression in MSCs and implantation into murine calvarial defect. Compared with: En1-silenced (loss-of-function) MSCs and implantation into murine calvarial defect; wild-type or control MSCs (details not specified).
En1 overexpression robustly enhanced osteoblastic differentiation, increasing RUNX2 protein level, alkaline phosphatase activity, and extracellular matrix mineralization En1 silencing produced opposite effects on osteoblastic differentiation markers En1-overexpressing MSCs significantly improved bone formation and microarchitectural parameters in murine calvarial defect model
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This identifies En1 as a candidate target for enhancing MSC-based bone repair strategies. However, clinicians and translational researchers should recognize this is early preclinical work requiring validation in larger animal models and eventual human studies before therapeutic application.
Sound preclinical study with gain- and loss-of-function design and in vivo validation in a bone defect model, but limited to animal model and lacks human clinical endpoints or translation.
As stated by the source record.
This identifies En1 as a candidate target for enhancing MSC-based bone repair strategies. However, clinicians and translational researchers should recognize this is early preclinical work requiring validation in larger animal models and eventual human studies before therapeutic application.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Engrailed 1 (En1) is a developmental transcription factor associated with skeletal formation; however, its functional role in mesenchymal stromal cell (MSC)-driven osteogenesis remains poorly understood. Here, we demonstrated that En1 is a critical regulator of adipose-derived MSCs differentiation into osteoblasts and bone repair induced by cell therapy using this MSC population. Using CRISPR-Cas9-based gain- and loss-of-function approaches in immortalized MSCs, we showed that En1 overexpression robustly enhanced osteoblastic differentiation, increasing RUNX2 protein level, alkaline phosphatase activity, and extracellular matrix mineralization, whereas En1 silencing produced the opposite effects. In a murine calvarial defect model, En1-overexpressing MSCs significantly improved bone formation and microarchitectural parameters, whereas En1-deficient MSCs impaired bone repair. Notably, temporal gene expression analyses revealed a dynamic, stage-dependent role for En1 during osteogenesis, consistent with the coordinated regulation of early commitment and later maturation. These effects were supported by consistent molecular, phenotypic, and in vivo outcomes. Collectively, our findings establish En1 as a key positive regulator of MSC-mediated osteogenesis and identify this transcription factor as a promising target for cell- and gene-based therapeutic strategies aimed at enhancing bone repair.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.